查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826776

2025年內視鏡逆行性造影（ERCP）全球市場報告

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，內視鏡逆行性造影(ERCP) 市場呈現強勁成長勢頭，市場規模將從 2024 年的 17.2 億美元成長至 2025 年的 18.6 億美元，複合年成長率達 8.4%。過去的成長主要歸因於各種慢性胃腸道疾病盛行率的上升、ERCP 應用的增加、胰臟癌發病率的上升、政府投資的增加以及醫療旅遊業的蓬勃發展。

預計未來幾年內視鏡逆行性造影(ERCP) 市場規模將強勁成長，到 2029 年將達到 25.8 億美元，複合年成長率為 8.5%。預測期內的成長可歸因於胃腸道疾病盛行率的上升、癌症發生率的上升、投資重點的增加、胰管疾病發生率的上升以及對內視鏡需求的不斷成長。預測期內的主要趨勢包括技術進步、研發夥伴關係、醫療基礎設施的擴展、政府醫療保健的擴大以及先進產品的開發。

內視鏡逆行性造影(ERCP) 是一種結合 X 光影像和內視鏡檢查的診斷和治療性醫療程序，用於治療膽管、膽囊和胰臟疾病。內視鏡檢查是指將一根帶燈的撓性導管（內視鏡）經由口腔插入小腸，以診斷和治療阻塞和結石等問題。

ERCP 使用的關鍵產品包括內視鏡、內視鏡治療設備、視覺化系統和能量設備。內視鏡是一種配有燈和攝影機的軟性管，可讓醫療保健專業人員在 ERCP 等手術過程中觀察內部器官，尤其是消化道。此手術可治療多種疾病，包括胃食道逆流症 (GERD)、消化道癌、巴瑞特氏食道症、膽道克隆氏症、消化性潰瘍、克隆氏症、腸阻塞和奧格爾維症候群。 ERCP 應用包括膽道括約肌切開術、膽道擴張、膽道置入術、胰臟括約肌切開術、胰管擴張和胰管支架置入術。主要最終使用者是醫院、診所、門診手術中心和其他醫療機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響，尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告隸屬於商業研究公司 (The Business Research Company) 的新報告系列，提供您在內鏡逆行胰造影(ERCP) 行業取得成功所需的數據，包括全球市場規模、區域佔有率、競爭對手的內視鏡逆行胰膽管造影(ERCP) 市場佔有率、詳細的內視鏡逆行性造影(ERCP) 市場細分市場和市場市場。本內視鏡逆行性造影(ERCP) 市場研究報告提供了完整的產業觀點，並對造影和未來情勢進行了詳細分析。

未來五年預測成長率為8.5%，較先前的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將阻礙美國市場的發展，導致來自美國和中國的內視鏡逆行造影(ERCP)導管導引線和膽道支架的成本上升，延長膽道阻塞的治療時間，並增加介入性胃腸病學的費用。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，關稅壁壘的影響也將更加廣泛。

胃腸道疾病的盛行率不斷上升，預計將推動內視鏡逆行性造影(ERCP) 市場的成長。這些疾病涵蓋影響胃腸道 (GI) 的各種狀況，包括口腔、食道、胃、腸、直腸、肛門、肝臟、膽囊、胰臟和其他附屬器官。飲食變化、老化、抗生素使用、生活習慣和環境影響等因素正在增加這些疾病的發生率。 ERCP 是一種微創解決方案，用於診斷和治療膽汁和胰管問題，例如膽結石、狹窄、腫瘤和感染疾病。例如，美國癌症協會估計，到 2024 年 1 月，美國將新增約 26,890 例胃癌病例，導致約 10,880 人死亡。隨著胃腸道疾病變得越來越普遍，對 ERCP 手術的需求也越來越大。

內視鏡逆行性胰膽管攝影 (ERCP) 市場中的公司正在透過開發膽管鏡系統等創新技術來推進該手術，以增強診斷和治療效果。這些系統可提供膽管和胰管的高解析度影像，進而改善治療效果。 2024 年 7 月，Penlon Limited 推出了 VedVision 膽管鏡直接視覺化系統，這是一款尖端設備，可為 ERCP 手術提供精確的影像。該系統配備 2 毫米附件通道和專用導管導引線通道，並配有切片檢查鉗、取石籃、細胞學刷和息肉切除勒除器等配件，從而增強了診斷和治療能力。

2022年10月，美國半導體製造商豪威科技公司（OmniVision Technologies Inc.）與AdaptivEndo LLC合作，開發了一個用於混合內視鏡和一次性內視鏡的統一平台。該平台旨在用於胃腸病學、肝病學、泌尿系統和婦科等多種醫學專科，並將簡化內視鏡逆行性造影（ERCP）等內視鏡操作。總部位於美國的AdaptivEndo LLC專注於生產結合超音波（EUS）和ERCP功能的一次性內視鏡設備，以提高臨床的多功能性和效率。

內視鏡逆行性造影(ERCP) 市場由提供診斷服務、治療服務、術後照護和後續照護等服務的營業單位所獲得的收益所構成。市場規模還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。內視鏡逆行性造影(ERCP) 市場還包括膽道支架、導管導引線和導管的銷售。該市場中的商品價值是“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球內視鏡逆行性胰造影(ERCP)：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球內視鏡逆行性造影（ERCP）市場：成長率分析
  • 全球內視鏡逆行性造影(ERCP) 市場表現：規模與成長，2019-2024 年
  • 全球內視鏡逆行性造影(ERCP) 市場預測：2024-2029 年、2034 年規模與成長
  • 全球內視鏡逆行性胰造影（ERCP）：總目標市場（TAM）

第6章 市場細分

  • 全球內視鏡逆行性造影(ERCP) 市場（依產品、效能及預測），2019-2024 年、2024-2029 年、2034 年
  • 內視鏡檢查
  • 內視鏡治療裝置
  • 視覺化系統
  • 能源設備
  • 全球內視鏡逆行性造影(ERCP) 市場（依疾病適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 胃食道逆流症（GERD）
  • 消化系統癌症
  • 巴瑞特氏食道症
  • 膽管疾病
  • 消化性潰瘍
  • 克隆氏症
  • 腸假性阻塞
  • 奧格爾維綜合症
  • 其他
  • 全球內視鏡逆行性造影(ERCP) 市場應用、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 膽道括約肌切開術
  • 膽道擴張
  • 膽道支架置入術
  • 胰臟括約肌切開術
  • 胰管擴張
  • 胰管支架置入術
  • 其他
  • 全球內視鏡逆行性造影(ERCP) 市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 門診手術中心
  • 其他
  • 全球內視鏡逆行性造影(ERCP) 市場：內視鏡細分市場、類型、效能與預測（2019-2024 年、2024-2029 年、2034 年）
  • 軟性內視鏡
  • 半硬式內視鏡
  • 高解析度內視鏡
  • 全球內視鏡逆行性造影(ERCP) 市場：內視鏡治療設備細分，依類型、性能及預測，2019-2024 年、2024-2029 年、2034 年
  • 去石裝置
  • 球囊擴張導管
  • 支架
  • 切片檢查
  • 全球內視鏡逆行性造影(ERCP) 市場：視覺化系統細分，依類型、效能與預測，2019-2024 年、2024-2029 年、2034 年
  • 高解析度視覺化系統
  • 內視鏡成像系統
  • 影像內視鏡
  • 全球內視鏡逆行性造影(ERCP) 市場：能量設備細分、按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 電外科設備
  • 雷射設備
  • 氬離子凝固系統

第7章 區域和國家分析

  • 全球內視鏡逆行性造影(ERCP) 市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球內視鏡逆行性造影(ERCP) 市場（依國家/地區、績效及預測）2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 內視鏡逆行性胰造影（ERCP）市場：競爭格局
  • 內視鏡逆行性造影（ERCP）市場：公司簡介
    • Medtronic plc
    • Fujifilm Holdings Corporation
    • Siemens Healthineers AG
    • Stryker Corporation
    • Boston Scientific Corporation

第31章：其他領先和創新企業

  • B. Braun Melsungen AG
  • Olympus Corporation
  • Ottomed Endoscopy
  • WL Gore & Associates Inc.
  • Streis plc
  • Cook Group
  • KARL STORZ SE & Co. KG
  • CONMED Corporation
  • PENTAX Medical Inc.
  • AMBU Inc.
  • Samsung Medison Co. Ltd.
  • Medi-Globe GmbH
  • Telemed System Inc.
  • Micro-Tech Endoscopy Inc.
  • Hobbs Medical Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年內視鏡逆行性造影(ERCP) 市場：提供新機會的國家
  • 2029年內視鏡逆行性胰造影（ERCP）市場：細分領域帶來新機會
  • 內視鏡逆行性造影(ERCP) 市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33700u

Endoscopic retrograde cholangiopancreatography (ERCP) is a diagnostic and therapeutic medical procedure that integrates endoscopy with X-ray imaging to address conditions affecting the bile ducts, gallbladder, and pancreas. The process involves inserting a flexible, illuminated tube (endoscope) through the mouth into the small intestine, enabling physicians to diagnose and treat issues such as blockages or stones.

The primary products used in ERCP include endoscopes, endotherapy devices, visualization systems, and energy devices. Endoscopes are flexible tubes with a light and camera, allowing healthcare professionals to visualize the internal organs, particularly the digestive tract, during procedures such as ERCP. The procedure addresses various disease indications, including gastroesophageal reflux disease (GERD), gastrointestinal cancer, Barrett's esophagus, bile duct diseases, peptic ulcer disease, Crohn's disease, intestinal pseudo-obstruction, Ogilvie syndrome, and others. ERCP applications include biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. The key end users are hospitals and clinics, ambulatory surgery centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The endoscopic retrograde cholangiopancreatography (ERCP) market research report is one of a series of new reports from The Business Research Company that provides endoscopic retrograde cholangiopancreatography (ERCP) market statistics, including endoscopic retrograde cholangiopancreatography (ERCP) industry global market size, regional shares, competitors with endoscopic retrograde cholangiopancreatography (ERCP) market share, detailed endoscopic retrograde cholangiopancreatography (ERCP) market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic retrograde cholangiopancreatography (ERCP) industry. This endoscopic retrograde cholangiopancreatography (ERCP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endoscopic retrograde cholangiopancreatography (ercp) market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to the rising prevalence of various chronic gastrointestinal diseases, rising application of ERCP, rising incidence of pancreatic cancer, rising investments by governments, and the rise in medical tourism.

The endoscopic retrograde cholangiopancreatography (ercp) market size is expected to see strong growth in the next few years. It will grow to $2.58 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the increasing prevalence of gastrointestinal conditions, rising incidence of cancer, growing focus on investments, increasing incidence of pancreatic duct, and rising demand for endoscopes. Major trends in the forecast period include technological advancements, partnerships for the R&D, expansion of the healthcare infrastructure, expansion of government healthcare, and development of advanced products.

The forecast of 8.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of endoscopic retrograde cholangiopancreatography(ERCP) guidewires and biliary stents sourced from Ireland and China, thereby prolonging biliary obstruction management and elevating interventional gastroenterology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of gastrointestinal conditions is anticipated to drive the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market. These conditions encompass a wide range of disorders affecting the gastrointestinal (GI) tract, including the mouth, esophagus, stomach, intestines, rectum, anus, and accessory organs such as the liver, gallbladder, and pancreas. Factors such as dietary changes, an aging population, antibiotic use, lifestyle habits, and environmental influences contribute to the increasing incidence of these conditions. ERCP provides a minimally invasive solution for diagnosing and treating bile and pancreatic duct issues, including gallstones, strictures, tumors, and infections. For example, the American Cancer Society estimated in January 2024 that approximately 26,890 new cases of stomach cancer would occur in the United States, with around 10,880 deaths expected. As gastrointestinal conditions become more common, the demand for ERCP procedures continues to grow.

Companies in the ERCP market are advancing procedures by developing innovative technologies, such as cholangioscope systems, for enhanced diagnosis and treatment. These systems provide high-resolution imaging of the bile and pancreatic ducts, improving therapeutic outcomes. In July 2024, Penlon Limited introduced the VedVision Cholangioscope Direct Visualization System, a cutting-edge device offering precise imaging for ERCP procedures. Its features include a 2 mm accessory channel and a dedicated guidewire channel, along with accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares, enhancing diagnostic and therapeutic capabilities.

In October 2022, OmniVision Technologies Inc., a semiconductor manufacturer based in the United States, collaborated with AdaptivEndo LLC to develop a unified platform for hybrid and single-use endoscopes. This platform is designed for use across various medical specialties, including gastroenterology, hepatology, urology, and gynecology, enabling a more streamlined approach to procedures such as endoscopic retrograde cholangiopancreatography (ERCP) and other endoscopic techniques. AdaptivEndo LLC, also based in the United States, specializes in single-use endoscopy devices that combine the functionalities of endoscopic ultrasound (EUS) and ERCP, offering enhanced versatility and efficiency in clinical practice.

Major players in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endoscopic retrograde cholangiopancreatography (ERCP) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endoscopic retrograde cholangiopancreatography (ERCP) market consists of revenues earned by entities by providing services such as diagnostic services, therapeutic services, post-operative, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The endoscopic retrograde cholangiopancreatography (ERCP) market also includes sales of biliary stents, guidewires, and catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endoscopic retrograde cholangiopancreatography (ercp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endoscopic retrograde cholangiopancreatography (ercp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endoscopic retrograde cholangiopancreatography (ercp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Endoscopes; Endotherapy Devices; Visualization Systems; Energy Devices
  • 2) By Disease Indication: Gastroesophageal Reflux Disease (GERD); Gastrointestinal Cancer; Barrett's Esophagus; Bile Duct Diseases; Peptic Ulcer Disease; Crohn's Disease; Intestinal Pseudo-Obstruction; Ogilvie Syndrome; Other Indications
  • 3) By Application: Biliary Sphincterotomy; Biliary Dilatation; Biliary Stenting; Pancreatic Sphincterotomy; Pancreatic Duct Dilatation; Pancreatic Duct Stentin
  • 4) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Other End Users
  • Subsegments:
  • 1) By Endoscopes: Flexible Endoscopes; Semi-Rigid Endoscopes; High-Resolution Endoscopes
  • 2) By Endotherapy Devices: Stone Extraction Devices; Balloon Dilatation Catheters; Stents; Biopsy Forceps
  • 3) By Visualization Systems: High-Definition Visualization Systems; Endoscopic Imaging Systems; Video Endoscopes
  • 4) By Energy Devices: Electrosurgical Devices; Laser Devices; Argon Plasma Coagulation Systems
  • Companies Mentioned: Medtronic plc; Fujifilm Holdings Corporation; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation; B. Braun Melsungen AG; Olympus Corporation; Ottomed Endoscopy; W. L. Gore & Associates Inc.; Streis plc; Cook Group; KARL STORZ SE & Co. KG; CONMED Corporation; PENTAX Medical Inc.; AMBU Inc.; Samsung Medison Co. Ltd.; Medi-Globe GmbH; Telemed System Inc.; Micro-Tech Endoscopy Inc.; Hobbs Medical Inc.; Shaili Endoscopy Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Characteristics

3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Trends And Strategies

4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Growth Rate Analysis
  • 5.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Total Addressable Market (TAM)

6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Segmentation

  • 6.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endoscopes
  • Endotherapy Devices
  • Visualization Systems
  • Energy Devices
  • 6.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gastroesophageal Reflux Disease (GERD)
  • Gastrointestinal Cancer
  • Barrett's Esophagus
  • Bile Duct Diseases
  • Peptic Ulcer Disease
  • Crohn's Disease
  • Intestinal Pseudo-Obstruction
  • Ogilvie Syndrome
  • Other Indications
  • 6.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biliary Sphincterotomy
  • Biliary Dilatation
  • Biliary Stenting
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Dilatation
  • Pancreatic Duct Stenting
  • Other Applications
  • 6.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgery Centers
  • Other End Users
  • 6.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endoscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flexible Endoscopes
  • Semi-Rigid Endoscopes
  • High-Resolution Endoscopes
  • 6.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endotherapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stone Extraction Devices
  • Balloon Dilatation Catheters
  • Stents
  • Biopsy Forceps
  • 6.7. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Visualization Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Definition Visualization Systems
  • Endoscopic Imaging Systems
  • Video Endoscopes
  • 6.8. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Energy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrosurgical Devices
  • Laser Devices
  • Argon Plasma Coagulation Systems

7. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Regional And Country Analysis

  • 7.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 8.1. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 9.1. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 9.2. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 10.1. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 11.1. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 11.2. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 12.1. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 13.1. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 14.1. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 14.2. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 15.1. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 15.2. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 16.1. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 17.1. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 18.1. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 19.1. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 20.1. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 21.1. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 21.2. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 22.1. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 23.1. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 23.2. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 24.1. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 24.2. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 25.1. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 25.2. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 26.1. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 26.2. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 27.1. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 28.1. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 28.2. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 29.1. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 29.2. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape And Company Profiles

  • 30.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape
  • 30.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Olympus Corporation
  • 31.3. Ottomed Endoscopy
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. Streis plc
  • 31.6. Cook Group
  • 31.7. KARL STORZ SE & Co. KG
  • 31.8. CONMED Corporation
  • 31.9. PENTAX Medical Inc.
  • 31.10. AMBU Inc.
  • 31.11. Samsung Medison Co. Ltd.
  • 31.12. Medi-Globe GmbH
  • 31.13. Telemed System Inc.
  • 31.14. Micro-Tech Endoscopy Inc.
  • 31.15. Hobbs Medical Inc.

32. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

34. Recent Developments In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

35. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market High Potential Countries, Segments and Strategies

  • 35.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer